Dr. Francois Bethoux, MD

NPI: 1790727469
Total Payments
$42,539
2024 Payments
$7,003
Companies
10
Transactions
51
Medicare Patients
949
Medicare Billing
$88,380

Payment Breakdown by Category

Consulting$21,965 (51.6%)
Other$17,880 (42.0%)
Travel$1,826 (4.3%)
Food & Beverage$868.10 (2.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $21,965 11 51.6%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $17,880 10 42.0%
Travel and Lodging $1,826 11 4.3%
Food and Beverage $868.10 19 2.0%

Top Paying Companies

Company Total Records Latest Year
Biogen, Inc. $26,175 36 $0 (2021)
E.R. Squibb & Sons, L.L.C. $6,890 5 $0 (2024)
Ipsen Biopharmaceuticals, Inc $3,695 2 $0 (2021)
Amneal Pharmaceuticals LLC $2,600 1 $0 (2022)
Genentech, Inc. $1,695 1 $0 (2020)
GW Pharma Limited $1,250 1 $0 (2020)
Celgene Corporation $99.47 1 $0 (2024)
Medtronic USA, Inc. $73.83 1 $0 (2017)
Penumbra, Inc. $34.69 1 $0 (2022)
TG Therapeutics, Inc. $26.54 2 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $7,003 7 E.R. Squibb & Sons, L.L.C. ($6,890)
2023 $13.37 1 TG Therapeutics, Inc. ($13.37)
2022 $2,635 2 Amneal Pharmaceuticals LLC ($2,600)
2021 $5,990 6 Ipsen Biopharmaceuticals, Inc ($3,650)
2020 $3,785 3 Genentech, Inc. ($1,695)
2019 $12,796 18 Biogen, Inc. ($12,751)
2018 $10,244 13 Biogen, Inc. ($10,244)
2017 $73.83 1 Medtronic USA, Inc. ($73.83)

All Payment Transactions

51 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
11/15/2024 E.R. Squibb & Sons, L.L.C. Consulting Fee Cash or cash equivalent $650.00 General
10/30/2024 E.R. Squibb & Sons, L.L.C. Consulting Fee Cash or cash equivalent $1,300.00 General
10/10/2024 E.R. Squibb & Sons, L.L.C. Consulting Fee Cash or cash equivalent $650.00 General
09/19/2024 TG Therapeutics, Inc. BRIUMVI (Drug) Food and Beverage In-kind items and services $13.17 General
Category: Immunology
08/20/2024 E.R. Squibb & Sons, L.L.C. Consulting Fee Cash or cash equivalent $650.00 General
07/09/2024 E.R. Squibb & Sons, L.L.C. Consulting Fee Cash or cash equivalent $3,640.00 General
03/06/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $99.47 General
Category: Neuroscience
05/30/2023 TG Therapeutics, Inc. BRIUMVI (Drug) Food and Beverage In-kind items and services $13.37 General
Category: Immunology
03/28/2022 Amneal Pharmaceuticals LLC LYVISPAH (Drug) Consulting Fee Cash or cash equivalent $2,600.00 General
Category: NEUROLOGY
01/19/2022 Penumbra, Inc. Real Immersive System (Device) Food and Beverage Cash or cash equivalent $34.69 General
Category: Neuro Rehabilitation
12/08/2021 Biogen, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $360.00 General
11/03/2021 Biogen, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $360.00 General
07/26/2021 Ipsen Biopharmaceuticals, Inc DYSPORT (Drug) Consulting Fee Cash or cash equivalent $3,650.00 General
Category: Neurology
06/15/2021 Biogen, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $540.00 General
03/22/2021 Biogen, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $540.00 General
03/16/2021 Biogen, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $540.00 General
06/27/2020 Genentech, Inc. Consulting Fee Cash or cash equivalent $1,695.00 General
05/04/2020 GW Pharma Limited Epidiolex (Drug) Consulting Fee Cash or cash equivalent $1,250.00 General
Category: Neurology
01/27/2020 Biogen, Inc. Consulting Fee Cash or cash equivalent $840.00 General
11/15/2019 Ipsen Biopharmaceuticals, Inc DYSPORT (Drug) Food and Beverage In-kind items and services $44.93 General
Category: Neurology
11/04/2019 Biogen, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,360.00 General
11/04/2019 Biogen, Inc. Travel and Lodging Cash or cash equivalent $228.85 General
11/04/2019 Biogen, Inc. Travel and Lodging Cash or cash equivalent $123.40 General
11/04/2019 Biogen, Inc. Food and Beverage Cash or cash equivalent $48.28 General
11/04/2019 Biogen, Inc. Travel and Lodging Cash or cash equivalent $7.50 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 216 403 $175,062 $20,600
2022 8 243 408 $169,516 $22,021
2021 7 257 460 $180,744 $25,534
2020 7 233 404 $151,173 $20,225
Total Patients
949
Total Services
1,675
Medicare Billing
$88,380
Procedure Codes
29

All Medicare Procedures & Services

29 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
64642 Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity Facility 2023 46 89 $53,400 $5,945 11.1%
64643 Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity Facility 2023 45 107 $47,401 $5,184 10.9%
64644 Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity Facility 2023 15 33 $21,813 $2,685 12.3%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 16 16 $12,810 $2,158 16.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 17 17 $9,962 $1,867 18.7%
95874 Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle Facility 2023 59 123 $16,482 $1,670 10.1%
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes Facility 2023 18 18 $13,194 $1,090 8.3%
64642 Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity Facility 2022 42 86 $46,870 $5,725 12.2%
64643 Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity Facility 2022 39 88 $35,464 $4,287 12.1%
99221 Initial hospital inpatient care per day, typically 30 minutes Facility 2022 43 43 $28,638 $3,290 11.5%
64644 Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity Facility 2022 11 23 $13,823 $2,035 14.7%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 16 16 $11,456 $2,002 17.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 19 19 $10,110 $1,979 19.6%
95874 Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle Facility 2022 52 110 $13,420 $1,471 11.0%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 21 23 $9,735 $1,234 12.7%
64642 Injection of chemical for destruction of nerve muscles on one arm or leg, 1-4 muscles Facility 2021 49 108 $58,860 $8,128 13.8%
64643 Injection of chemical for destruction of nerve muscles on arm or leg, 1-4 muscles, each additional extremity Facility 2021 37 96 $38,688 $5,199 13.4%
99221 Initial hospital inpatient care, typically 30 minutes per day Facility 2021 50 50 $28,465 $3,951 13.9%
64644 Injection of chemical for destruction of nerve muscles on one arm or leg, 5 or more muscles Facility 2021 13 27 $16,227 $2,526 15.6%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 31 35 $13,355 $2,016 15.1%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 19 19 $9,899 $1,872 18.9%
95874 Needle measurement and recording of electrical activity of muscles for guidance with injection of chemical for destruction of muscles Facility 2021 58 125 $15,250 $1,842 12.1%
64642 Injection of chemical for destruction of nerve muscles on arm or leg, 1-4 muscles Facility 2020 49 95 $51,775 $6,883 13.3%
64643 Injection of chemical for destruction of nerve muscles on arm or leg, 1-4 muscles Facility 2020 38 78 $31,434 $3,966 12.6%
64644 Injection of chemical for destruction of nerve muscles on arm or leg, 5 or more muscles Facility 2020 15 33 $19,833 $2,766 13.9%

About Dr. Francois Bethoux, MD

Dr. Francois Bethoux, MD is a Physical Medicine & Rehabilitation healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790727469.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Francois Bethoux, MD has received a total of $42,539 in payments from pharmaceutical and medical device companies, with $7,003 received in 2024. These payments were reported across 51 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($21,965).

As a Medicare-enrolled provider, Bethoux has provided services to 949 Medicare beneficiaries, totaling 1,675 services with total Medicare billing of $88,380. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.

Practice Information

  • Specialty Physical Medicine & Rehabilitation
  • Location Cleveland, OH
  • Active Since 06/10/2006
  • Last Updated 12/21/2007
  • Taxonomy Code 208100000X
  • Entity Type Individual
  • NPI Number 1790727469

Products in Payments

  • DYSPORT (Drug) $3,695
  • LYVISPAH (Drug) $2,600
  • Epidiolex (Drug) $1,250
  • ZEPOSIA (Drug) $99.47
  • SYNCHROMED (Device) $73.83
  • Real Immersive System (Device) $34.69
  • BRIUMVI (Drug) $26.54

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physical Medicine & Rehabilitation Doctors in Cleveland